Dazenta Tablets (Linagliptin)
Linagliptin 5mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.
MFDS item code 201900149 · Approved 2019.01.11
This product's status changed to Expired on 2024.01.11. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of glycemic control in type 2 diabetes mellitus
This medication helps effectively control blood sugar levels in patients with type 2 diabetes. It can be used alone in the initial treatment, and if adequate blood sugar control is difficult with monotherapy, it can be taken in combination with metformin. Additionally, when blood sugar control is poor with metformin or sulfonylureas, this medication can be used in combination to better manage blood sugar levels. It can be combined with insulin therapy or in cases where it is difficult to control levels even with combination therapy of sulfonylureas and metformin, thereby enhancing treatment effects. This medication is used to improve blood sugar control in conjunction with various diabetes treatments.
The recommended dose of this medicine is 5mg once daily. It may be administered with or without food. When coadministered with insulin or an insulin secretagogue (such as a sulfonylurea), a lower dose of insulin and the insulin secretagogue may be required to minimize the risk of hypoglycemia.
This medication should not be used by patients who are allergic to its active ingredient or other components. It should not be administered to patients with type 1 diabetes or diabetic ketoacidosis. Caution is needed when used with insulin or sulfonylureas that can cause hypoglycemia, as the risk of hypoglycemia may increase, and dosage adjustments may be necessary. The use of this medication is not recommended in patients with heart failure, especially those with severe heart failure, and caution should be exercised in mild heart failure patients. Acute pancreatitis may occur, so if severe abdominal pain or other symptoms appear, the medication should be discontinued immediately and a doctor should be consulted. Skin disorders such as bullous pemphigoid may occur, and immediate medical attention should be sought if blisters or skin breakdown develop. If joint pain worsens or is accompanied by disability during use of this medication, discontinuation should be considered. The use of this medication is not recommended during pregnancy or breastfeeding, and it is advisable to consult with a healthcare provider. Safety and efficacy in pediatric patients have not been established; therefore, it is not recommended for children. There is no need for specific dosage adjustments in the elderly; however, it can be administered to patients with reduced renal or liver function without dose modification. In case of overdose, remove any unabsorbed medication from the gastrointestinal tract and observe symptoms, and obtain appropriate treatment if necessary. This medication should be stored out of reach of children, and transferring it to another container may pose risks of accidents and quality deterioration, so caution should be exercised.
Hypoglycemia, acute pancreatitis, bullous pemphigoid, nasopharyngitis, hypersensitivity reaction, angioedema, urticaria, hypertriglyceridemia, hyperlipidemia, cough, constipation, oral ulcers, rash, severe joint pain accompanied by disability, rhabdomyolysis, weight gain, increased lipase, increased amylase, dyspepsia, edema, facial swelling, peripheral edema, weight loss, increased appetite, constipation, upper abdominal pain, enterocolitis, intestinal obstruction, gastritis, herpes zoster, cystitis, acute pyelonephritis, bronchitis, vestibular neuronitis, sepsis, pneumonia, decreased appetite, dehydration, hyperglycemia, decreased appetite, cerebral infarction, stuttering, Alzheimer's-type dementia, chest pain, fever, facial swelling, fatigue, death, fatigue, chronic obstructive pulmonary disease, asthma, diabetic foot disease, skin lesions, liver metastasis, acute leukemia, basal cell carcinoma, non-small cell lung cancer, malignant pericardial effusion, gastric cancer, rectal cancer, pancreatic cancer, meniscal injury, pneumoconiosis, congestive heart failure, angina pectoris, acute myocardial infarction, unstable angina, cardiac arrest, diabetic retinopathy, acute kidney injury, end-stage renal disease, acute cholangitis, acute cholecystitis, cholangitis, dizziness, kidney transplantation failure, dyspepsia, edema, facial swelling, peripheral edema, weight loss, increased appetite, abdominal pain, gastrointestinal disorders, irritable bowel syndrome, burning mouth syndrome, colitis, abdominal discomfort, dysphagia, gastric ulcer, gum bleeding, intestinal obstruction, tooth loss, hemorrhoids, lower abdominal pain, diarrhea, vomiting, gastritis, gastrointestinal disorders, irritable bowel syndrome, acute pyelonephritis, bronchitis, acanthosis nigricans, allergic rhinitis, soft tissue infection, pharyngitis, vestibular neuronitis, scrub typhus, periodontitis, sepsis, tonsillitis, laryngitis, viral upper respiratory infection, pneumonia, tonsillitis, decreased appetite, hypercholesterolemia, inadequate diabetes control, malnutrition, hyponatremia, dehydration, hyperglycemia, decreased appetite, inadequate diabetes control, cerebral infarction, diabetic neuropathy, headache, stuttering, paresthesia, postherpetic neuralgia, hemiplegia, syncope, Alzheimer's-type dementia, drowsiness, diabetic neuropathy, stuttering, drowsiness, fatigue, chest discomfort, asthenia, death, pain, fatigue, nosebleed, oropharyngeal pain, chronic obstructive pulmonary disease, voice disorders, allergic rhinitis, exertional dyspnea, wet cough, asthma, runny nose, pulmonary mass, joint pain, osteoporosis, arthropathy, musculoskeletal discomfort, myositis, myalgia, soft tissue mass, postmenopausal osteoporosis, rotator cuff syndrome, joint pain, increased serum triglycerides, increased urine albumin/creatinine ratio, positive urine leukocyte, decreased hemoglobin, increased serum potassium, increased serum creatinine, increased serum creatine phosphokinase, increased ALT, increased serum triglycerides, male pattern baldness, diabetic foot disease, hyperhidrosis, hair loss, skin lesions, dermatitis, liver metastasis, acute leukemia, basal cell carcinoma, non-small cell lung cancer, malignant pericardial effusion, benign duodenal neoplasm, benign skin neoplasm, gastric cancer, rectal cancer, pancreatic cancer, anxiety, affective disorder, insomnia, depression, anxiety, bruise, bone bruise, concussion, meniscal injury, foot fracture, hand fracture, pneumoconiosis, laceration, congestive heart failure, angina pectoris, acute myocardial infarction, palpitations, unstable angina, cardiac arrest, diabetic retinopathy, dry eye, glaucoma, cataract, ocular discomfort, allergic conjunctivitis, dry eye, cataract, acute kidney injury, polyuria, proteinuria, end-stage renal disease, stress urinary incontinence, hematuria, polyuria, hypotension, flushing, fatty liver, acute cholangitis, acute cholecystitis, cholangitis, cholelithiasis, hearing loss, dizziness, erectile dysfunction, goiter, kidney transplantation failure, anemia, nausea, diarrhea, upper abdominal pain, vomiting, gastroesophageal reflux disease, gastritis, nausea, upper abdominal pain, viral upper respiratory infection, upper respiratory infection, gastroenteritis, pneumonia, herpes zoster, cystitis, hyperglycemia, dizziness, sensory loss, dizziness, chest pain, fever, dyspnea, osteoarthritis, limb pain, increased ALT, increased AST, itching, itching, insomnia, depression, hypertension, dizziness, benign prostatic hyperplasia
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is best to maintain the storage temperature between 1 degree and 30 degrees Celsius at room temperature.
Light pink round film-coated tablets
28 tablets [14 tablets/PTPX2], 30 tablets [10 tablets/PTPX3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Linagliptin 5mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
International Pharmaceutical Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Aju Pharmaceuticals Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Albozen Korea Co., Ltd.
Linagliptin 5mg
Tablet · Prescription medication
Anguk Pharmaceutical Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.